Anteris Technologies Looks Bullish If DurAVR's PARADIGM Delivers [Seeking Alpha]
Anteris Technologies Global Corp. (AVR)
Company Research
Source: Seeking Alpha
AVR's PARADIGM pivotal trial is the central catalyst. This will compare DurAVR against commercial valves across 85 sites in the US, Europe, and Canada. I believe that Medtronic's 16.2% stake also offers strategic validation of AVR's underlying valve technology. And, after AVR's recent raises, its balance sheet seems well capitalized despite ongoing cash burn. AVR remains speculative until they receive full regulatory approvals. But I feel the upside potential justifies those risks in the long run. SweetBunFactory/iStock via Getty Images Anteris Technologies Global Corp. ( AVR ) is a structural heart company. They're developing the DurAVR transcatheter heart valve (THV), which is their lead product. This is a novel biomimetic device that has treated more than 130 patients in trials
Show less
Read more
Impact Snapshot
Event Time:
AVR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AVR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AVR alerts
High impacting Anteris Technologies Global Corp. news events
Weekly update
A roundup of the hottest topics
AVR
News
- Anteris Technologies Global (AVR) had its "overweight" rating reaffirmed by Cantor Fitzgerald. They now have a $15.00 price target on the stock.MarketBeat
- Anteris Technologies Global (AVR) is now covered by Cantor Fitzgerald. They set an "overweight" rating and a $15.00 price target on the stock.MarketBeat
- Anteris Technologies Global (AVR) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $16.00 price target on the stock.MarketBeat
- Anteris Technologies Global (AVR) was upgraded by Cantor Fitzgerald to "strong-buy".MarketBeat
- Anteris Technologies Global Highlights DurAVR TAVR Data, PARADIGM Pivotal Trial Plans at TD Cowen Conference [Yahoo! Finance]Yahoo! Finance
AVR
Sec Filings
- 3/18/26 - Form 424B3
- 3/16/26 - Form EFFECT
- 3/10/26 - Form POS
- AVR's page on the SEC website